Lexaria Bioscience Corp.·4

Feb 12, 1:13 PM ET

DOCHERTY JOHN MARTIN 4

4 · Lexaria Bioscience Corp. · Filed Feb 12, 2020

Insider Transaction Report

Form 4
Period: 2020-02-07
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
  • Award

    Stock Options

    2020-02-07+550,0001,250,000 total
    Exercise: $0.47From: 2020-02-07Exp: 2025-02-07Common Shares (550,000 underlying)
Holdings
  • common shares

    (indirect: Private Holding Company)
    1,622,250
  • Stock Options

    Exercise: $0.11From: 2016-04-15Exp: 2021-04-15Common Shares (300,000 underlying)
    300,000
  • Stock Options

    Exercise: $1.53From: 2018-05-31Exp: 2023-05-31Common Shares (400,000 underlying)
    700,000

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT